Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced the completion of its Phase IIa clinical study for 9MW1911, a self-developed ...

The 2026 version of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report has been published. Key ...

In conjunction with World Chronic Obstructive Pulmonary Disease (COPD) Day, organised by the World Health Organisation and ...

To keep up with COPD research and care developments, the 2026 Global Initiative for Chronic Obstructive Lung Disease report ...

The GOLD COPD Update 2026 provides updated guidance on case-finding, disease activity, exacerbation management.

A recent study explored exacerbation history to determine what it revealed about prognosis. The findings suggested that exacerbation severity history was predictive of future exacerbation status.

Please provide your email address to receive an email when new articles are posted on . Minimum pitch in the morning was significantly higher at exacerbation onset and peak vs. baseline. In the ...

According to a recent study, patients with an exacerbation of chronic obstructive pulmonary disease (COPD) have greater risks of both subsequent exacerbations and mortality. The odds of subsequent ...

Investigators of a 3-year observational study identified independent risk factors for exacerbations related to chronic obstructive pulmonary disease (COPD) and successfully developed a novel risk ...

Chronic obstructive pulmonary disease (COPD) is straining Europe’s healthcare budgets, primarily through preventable ...